Stocks and Investing Stocks and Investing
Thu, April 18, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Jonathan Wolleben Reiterated (SVRA) at Buy and Held Target at $8 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Timothy Wojs Maintained (TGLS) at Buy with Increased Target to $65 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Justin Bowers Maintained (TECH) at Strong Buy with Decreased Target to $82 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Matthew Kaplan Reiterated (TGTX) at Strong Buy and Held Target at $39 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Eric Joseph Reiterated (TGTX) at Buy and Held Target at $25 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Edward White Reiterated (TGTX) at Strong Buy and Held Target at $45 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Alexander Paris Maintained (SSSS) at Buy and Held Target at $6 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Timothy Wojs Maintained (SSD) at Buy with Increased Target to $215 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Brian Schwartz Initiated (SPT) at Buy and Held Target at $76 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Brian Kinstlinger Initiated (SPIR) at Strong Buy and Held Target at $22 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Matthew Harrigan Maintained (SPOT) at Strong Buy with Increased Target to $325 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Andrew Didora Maintained (UAL) at Strong Buy with Increased Target to $70 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Ravi Shanker Maintained (UAL) at Buy with Increased Target to $80 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Christopher Stathoulopoulos Maintained (UAL) at B .. y with Increased Target to $60 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Savanthi Syth Maintained (UAL) at Buy with Increased Target to $70 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Justin Bowers Maintained (TXG) at Strong Buy with Decreased Target to $55 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Ryan Todd Maintained (TTE) at Hold with Increased Target to $79 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Trevor Cranston Reiterated (TWO) at Buy and Held Target at $15 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Charles Shi Reiterated (TSM) at Strong Buy and Held Target at $168 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Emmanuel Rosner Downgraded (TSLA) to Hold and Decreased Target to $123 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Kristen Kluska Reiterated (TSHA) at Buy and Held Target at $7 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Meyer Shields Maintained (TRV) at Hold with Decreased Target to $231 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Harry Fong Maintained (TRV) at Strong Buy and Held Target at $240 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
David Motemaden Maintained (TRV) at Buy with Decreased Target to $250 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Mark Dwelle Maintained (TRV) at Hold with Decreased Target to $225 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Connor Lynagh Downgraded (TS) to Sell and Held Target at $40 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Martin Yang Reiterated (TRNS) at Buy with Increased Target to $125 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Scott Devitt Reiterated (TRIP) at Hold and Held Target at $30 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Oliver Chen Maintained (ULTA) at Strong Buy with Decreased Target to $520 on, Apr 18th, 2024
[ Thu, Apr 18th 2024 ] - WOPRAI
Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $54 on, Apr 18th, 2024

Raghuram Selvaraju Reiterated (URGN) at Strong Buy and Held Target at $54 on, Apr 18th, 2024


Published on 2024-10-28 10:28:09 - WOPRAI, Raghuram Selvaraju
  Print publication without navigation


Raghuram Selvaraju of HC Wainwright & Co., Reiterated "UroGen Pharma Ltd." (URGN) at Strong Buy and Held Target at $54 on, Apr 18th, 2024.

Raghuram has made no other calls on URGN in the last 4 months.



There is 1 other peer that has a rating on URGN. Out of the 1 peers that are also analyzing URGN, 0 agree with Raghuram's Rating of Hold.



This is the rating of the analyst that currently disagrees with Raghuram

  • Leland Gershell of "Oppenheimer" Maintained at Buy with Decreased Target to $34 on, Friday, March 15th, 2024
Contributing Sources